756 related articles for article (PubMed ID: 11840453)
21. Angiotensin II increases expression of cyclooxygenase-2: implications for the function of vascular smooth muscle cells.
Hu ZW; Kerb R; Shi XY; Wei-Lavery T; Hoffman BB
J Pharmacol Exp Ther; 2002 Nov; 303(2):563-73. PubMed ID: 12388637
[TBL] [Abstract][Full Text] [Related]
22. Transactivation of the PPAR-responsive enhancer module in chemopreventive glutathione S-transferase gene by the peroxisome proliferator-activated receptor-gamma and retinoid X receptor heterodimer.
Park EY; Cho IJ; Kim SG
Cancer Res; 2004 May; 64(10):3701-13. PubMed ID: 15150131
[TBL] [Abstract][Full Text] [Related]
23. The peroxisome proliferator response element of the gene encoding the peroxisomal beta-oxidation enzyme enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase is a target for constitutive androstane receptor beta/9-cis-retinoic acid receptor-mediated transactivation.
Kassam A; Winrow CJ; Fernandez-Rachubinski F; Capone JP; Rachubinski RA
J Biol Chem; 2000 Feb; 275(6):4345-50. PubMed ID: 10660604
[TBL] [Abstract][Full Text] [Related]
24. Basic calcium phosphate crystal-induced prostaglandin E2 production in human fibroblasts: role of cyclooxygenase 1, cyclooxygenase 2, and interleukin-1beta.
Morgan MP; Whelan LC; Sallis JD; McCarthy CJ; Fitzgerald DJ; McCarthy GM
Arthritis Rheum; 2004 May; 50(5):1642-9. PubMed ID: 15146435
[TBL] [Abstract][Full Text] [Related]
25. Effect of a selective cyclooxygenase-2 inhibitor, nimesulide, on the growth of lung tumors and their expression of cyclooxygenase-2 and peroxisome proliferator- activated receptor-gamma.
Shaik MS; Chatterjee A; Singh M
Clin Cancer Res; 2004 Feb; 10(4):1521-9. PubMed ID: 14977856
[TBL] [Abstract][Full Text] [Related]
26. Statins activate peroxisome proliferator-activated receptor gamma through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages.
Yano M; Matsumura T; Senokuchi T; Ishii N; Murata Y; Taketa K; Motoshima H; Taguchi T; Sonoda K; Kukidome D; Takuwa Y; Kawada T; Brownlee M; Nishikawa T; Araki E
Circ Res; 2007 May; 100(10):1442-51. PubMed ID: 17463321
[TBL] [Abstract][Full Text] [Related]
27. T-cell-derived interleukin-17 regulates the level and stability of cyclooxygenase-2 (COX-2) mRNA through restricted activation of the p38 mitogen-activated protein kinase cascade: role of distal sequences in the 3'-untranslated region of COX-2 mRNA.
Faour WH; Mancini A; He QW; Di Battista JA
J Biol Chem; 2003 Jul; 278(29):26897-907. PubMed ID: 12746433
[TBL] [Abstract][Full Text] [Related]
28. PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease.
Marx N; Bourcier T; Sukhova GK; Libby P; Plutzky J
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):546-51. PubMed ID: 10073956
[TBL] [Abstract][Full Text] [Related]
29. Effects of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) on the expression of inflammatory cytokines and apoptosis induction in rheumatoid synovial fibroblasts and monocytes.
Ji JD; Cheon H; Jun JB; Choi SJ; Kim YR; Lee YH; Kim TH; Chae IJ; Song GG; Yoo DH; Kim SY; Sohn J
J Autoimmun; 2001 Nov; 17(3):215-21. PubMed ID: 11712859
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of tumor necrosis factor alpha-induced prostaglandin E2 production by the antiinflammatory cytokines interleukin-4, interleukin-10, and interleukin-13 in osteoarthritic synovial fibroblasts: distinct targeting in the signaling pathways.
Alaaeddine N; Di Battista JA; Pelletier JP; Kiansa K; Cloutier JM; Martel-Pelletier J
Arthritis Rheum; 1999 Apr; 42(4):710-8. PubMed ID: 10211885
[TBL] [Abstract][Full Text] [Related]
31. PPARalpha activation by Wy 14643 induces transactivation of the rat UCP-1 promoter without increasing UCP-1 mRNA levels and attenuates PPARgamma-mediated increases in UCP-1 mRNA levels induced by rosiglitazone in fetal rat brown adipocytes.
Teruel T; Clapham JC; Smith SA
Biochem Biophys Res Commun; 1999 Oct; 264(2):311-5. PubMed ID: 10529360
[TBL] [Abstract][Full Text] [Related]
32. Cyclooxygenase-2 is induced in monocytes by peroxisome proliferator activated receptor gamma and oxidized alkyl phospholipids from oxidized low density lipoprotein.
Pontsler AV; St Hilaire A; Marathe GK; Zimmerman GA; McIntyre TM
J Biol Chem; 2002 Apr; 277(15):13029-36. PubMed ID: 11809750
[TBL] [Abstract][Full Text] [Related]
33. The short heterodimer partner receptor differentially modulates peroxisome proliferator-activated receptor alpha-mediated transcription from the peroxisome proliferator-response elements of the genes encoding the peroxisomal beta-oxidation enzymes acyl-CoA oxidase and hydratase-dehydrogenase.
Kassam A; Capone JP; Rachubinski RA
Mol Cell Endocrinol; 2001 May; 176(1-2):49-56. PubMed ID: 11369442
[TBL] [Abstract][Full Text] [Related]
34. Feedback control of cyclooxygenase-2 expression through PPARgamma.
Inoue H; Tanabe T; Umesono K
J Biol Chem; 2000 Sep; 275(36):28028-32. PubMed ID: 10827178
[TBL] [Abstract][Full Text] [Related]
35. Subtype- and response element-dependent differences in transactivation by peroxisome proliferator-activated receptors alpha and gamma.
Kassam A; Hunter J; Rachubinski RA; Capone JP
Mol Cell Endocrinol; 1998 Jun; 141(1-2):153-62. PubMed ID: 9723896
[TBL] [Abstract][Full Text] [Related]
36. Nonsteroidal anti-inflammatory drugs induce apoptosis in association with activation of peroxisome proliferator-activated receptor gamma in rheumatoid synovial cells.
Yamazaki R; Kusunoki N; Matsuzaki T; Hashimoto S; Kawai S
J Pharmacol Exp Ther; 2002 Jul; 302(1):18-25. PubMed ID: 12065695
[TBL] [Abstract][Full Text] [Related]
37. Peroxisome proliferator-activated receptors and hepatic stellate cell activation.
Miyahara T; Schrum L; Rippe R; Xiong S; Yee HF; Motomura K; Anania FA; Willson TM; Tsukamoto H
J Biol Chem; 2000 Nov; 275(46):35715-22. PubMed ID: 10969082
[TBL] [Abstract][Full Text] [Related]
38. PPARalpha activators inhibit vascular endothelial growth factor receptor-2 expression by repressing Sp1-dependent DNA binding and transactivation.
Meissner M; Stein M; Urbich C; Reisinger K; Suske G; Staels B; Kaufmann R; Gille J
Circ Res; 2004 Feb; 94(3):324-32. PubMed ID: 14684628
[TBL] [Abstract][Full Text] [Related]
39. PPARgamma ligands induce prostaglandin production in vascular smooth muscle cells: indomethacin acts as a peroxisome proliferator-activated receptor-gamma antagonist.
Bishop-Bailey D; Warner TD
FASEB J; 2003 Oct; 17(13):1925-7. PubMed ID: 12897060
[TBL] [Abstract][Full Text] [Related]
40. Effects of peroxisome proliferator-activated receptor agonists on LPS-induced neuronal death in mixed cortical neurons: associated with iNOS and COX-2.
Kim EJ; Kwon KJ; Park JY; Lee SH; Moon CH; Baik EJ
Brain Res; 2002 Jun; 941(1-2):1-10. PubMed ID: 12031542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
